INVO FertilityIVF -2.59%35 FCF Margin % is -95.14% as of Mar. 2026. GuruFocus rates IVF with a GF Score™ of 35/100 and a GF Value™ of $134.71 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, INVO Fertility ranks worse than 82.35% on this metric.
The historical rank and industry rank for INVO Fertility's FCF Margin % or its related term are showing as below:
IVF'
s FCF Margin % Range Over the Past 10 Years
Min: -804.87 Med: -145.96 Max: 84.86
Current: -75.02
During the past 13 years, the highest FCF Margin % of INVO Fertility was 84.86%. The lowest was -804.87%. And the median was -145.96%.
IVF's FCF Margin % is ranked worse than 82.35% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.375
vs IVF: -75.02
INVO Fertility FCF Margin % Related Terms
INVO Fertility FCF Margin % Historical Data
* Premium members only.
The historical data trend for INVO Fertility's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, INVO Fertility's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
INVO Fertility FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, INVO Fertility's FCF Margin % distribution charts can be found below:
* The bar in red indicates where INVO Fertility's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INVO Fertility (IVF) has a FCF Margin % of -95.14% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on INVO Fertility and its competitors. According to the industry distribution chart, INVO Fertility ranks #672 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 82.4%.
Is INVO Fertility's FCF Margin % too high?
INVO Fertility's current FCF Margin % is -95.14%. Based on the distribution chart, INVO Fertility ranks #672 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, INVO Fertility has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does INVO Fertility's FCF Margin % compare to RMSL and ADMT?
According to the Medical Devices & Instruments industry distribution chart, INVO Fertility ranks #672 out of 816 companies for FCF Margin %. This places INVO Fertility in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on INVO Fertility and its competitors. INVO Fertility's current FCF Margin % is -95.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INVO Fertility stock overvalued right now?
Based on GuruFocus' analysis, INVO Fertility (IVF) is currently considered Possible Value Trap. The stock's GF Value™ is $134.71, compared to a current price of $1.13 — trading 99.2% below its estimated fair value. The current FCF Margin % is -95.14%. INVO Fertility's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For INVO Fertility (IVF), the current FCF Margin % is -95.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is INVO Fertility (IVF) Overvalued in 2026?
Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued.
The current stock price of $1.13 is trading 99.2% below its estimated GF Value™ of $134.71.
GuruFocus considers INVO Fertility to be Possible Value Trap.
Key valuation signals for IVF:
FCF Margin %: -95.14%
GF Value™: $134.71 vs. price of $1.13 (99.2% below fair value)
No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score
Get the complete analysis for IVF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVF has been successfully added to your 
